Weiss Asset Management’s Apexigen, Inc. Common Stock APGN Stock Holding History

Weiss Asset Management’s Portfolio APGN Stock Details APGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-29,034	Closed	-$295K	–	747
2022 Q2	$295K	Hold	29,034	–	–	0.01%	522
2022 Q1	$293K	Hold	29,034	–	–	0.01%	670
2021 Q4	$291K	Buy	29,034 +2,880	+11%	+$28.7K	0.01%	584
2021 Q3	$260K	Hold	26,154	–	–	0.01%	439
2021 Q2	$259K	Buy	+26,154	New	+$259K	0.01%	441

Other funds holding APGN

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Yu Fan $97M AUM 57.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Weiss Asset Management's APGN Position: Q3 2022 in Review

Weiss Asset Management sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2022, closing a stake of 29,034 shares — an estimated $295K sold.

Weiss Asset Management first reported a position in APGN in Q2 2021 and held it in 5 quarters. The position peaked at $295K in Q2 2022. 18 funds tracked by Wall St. Rank hold APGN as of Q3 2022.

Weiss Asset Management reported no remaining Apexigen, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Weiss Asset Management sold 29,034 Apexigen, Inc. Common Stock shares in Q3 2022, an estimated $295K.
Weiss Asset Management first reported a position in Apexigen, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Weiss Asset Management's Apexigen, Inc. Common Stock position peaked at $295K in Q2 2022.
18 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2022.

Based on Weiss Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.